欧洲辅助性腹膜透析的可及性:呼吁增加并平等可及
欧洲多位肾脏病专家组成小组,通过问卷了解13个欧洲国家辅助性腹膜透析(asPD)的可及性。结果显示仅5个国家提供公共资金报销,asPD的使用取决于对腹膜透析的整体态度,所有受访者均提及需开展肾脏病团队教育和患者教育。小组呼吁欧洲所有国家和肾脏中心均应提供asPD,并将教育、患者讨论和政策参与列为优先事项。
要点
- 13个调查国家中仅5国为辅助性腹膜透析提供公共资金报销。
- 所有受访者均提及需开展肾脏病团队教育和患者教育并让患者参与透析方式决策。
- 作者呼吁欧洲所有国家和肾脏中心均应提供辅助性腹膜透析。
核心结论
- 许多晚期肾病患者更愿意在家透析,但体弱患者选择腹膜透析时多数医疗系统无法提供其选择。
- 辅助性腹膜透析应在欧洲所有国家和所有肾脏中心可用。
研究设计与样本
- 欧洲一组肾脏病专家成立小组,成员填写包含个人经验、国家经验、辅助人员、资金、障碍、增长需求和三大优先事项等条目的问卷。
- 调查覆盖13个国家。
主要发现
- 13个调查国家中仅5个国家提供公共资金报销辅助性腹膜透析。
- 辅助性腹膜透析的使用取决于对腹膜透析的整体态度,所有受访者均提及需要肾脏病团队教育和/或患者教育及让患者参与透析方式决策。
临床怎么用
- 作者认为实现可及性的三大优先事项是:教育肾脏病医护团队了解腹膜透析的优势,在患者及其家庭接近需要透析时进行教育和讨论,以及与政策制定者和医疗提供者接触以发展和支持辅助性腹膜透析。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Availability of assisted PD (asPD) increases access to dialysis at home, particularly for the increasing numbers of older and frail people with advanced kidney disease. Although asPD has been widely used in some European countries for many years, it remains unavailable or poorly utilized in others. A group of leading European nephrologists have therefore formed a group to drive increased availability of asPD in Europe and in their own countries. METHODS: Members of the group filled in a proforma with the following headings: personal experience, country experience, who are the assistants, funding of asPD, barriers to growth, what is needed to grow and their top three priorities. RESULTS: Only 5 of the 13 countries surveyed provided publicly funded reimbursement for asPD. The use of asPD depends on overall attitudes to PD, with all respondents mentioning the need for nephrology team education and/or patient education and involvement in dialysis modality decision making. CONCLUSIONS AND CALL TO ACTION: Many people with advanced kidney disease would prefer to have their dialysis at home, yet if the frail patient chooses PD most healthcare systems cannot provide their choice. AsPD should be available in all countries in Europe and in all renal centres. The top priorities to make this happen are education of renal healthcare teams about the advantages of PD, education of and discussion with patients and their families as they approach the need for dialysis, and engagement with policymakers and healthcare providers to develop and support assistance for PD.
引用
- Brown EA, Ekstrand A, Gallieni M, et al. Availability of assisted peritoneal dialysis in Europe: call for increased and equal access. Nephrol Dial Transplant. 2022. PMID: 35671088. doi:10.1093/ndt/gfac193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。